5-amino-N-(2-amino-2-oxoethyl)-6-(6-methyl-1H-benzimidazol-2-yl)pyrazine-2-carboxamide;5-amino-N-(cyclopentylmethyl)-6-(6-methyl-1H-benzimidazol-2-yl)pyrazine-2-carboxamide;5-amino-6-(6-methyl-1H-benzimidazol-2-yl)-N-(oxolan-2-ylmethyl)pyrazine-2-carboxamide;[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]-morpholin-4-ylmethanone;5-amino-6-(6-methyl-1H-benzimidazol-2-yl)-N-(2-pyrrolidin-1-ylethyl)pyrazine-2-carboxamide;molecular hydrogen

C88H134N32O8 — CID 159647198

About 5-amino-N-(2-amino-2-oxoethyl)-6-(6-methyl-1H-benzimidazol-2-yl)pyrazine-2-carboxamide;5-amino-N-(cyclopentylmethyl)-6-(6-methyl-1H-benzimidazol-2-yl)pyrazine-2-carboxamide;5-amino-6-(6-methyl-1H-benzimidazol-2-yl)-N-(oxolan-2-ylmethyl)pyrazine-2-carboxamide;[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]-morpholin-4-ylmethanone;5-amino-6-(6-methyl-1H-benzimidazol-2-yl)-N-(2-pyrrolidin-1-ylethyl)pyrazine-2-carboxamide;molecular hydrogen

5-amino-N-(2-amino-2-oxoethyl)-6-(6-methyl-1H-benzimidazol-2-yl)pyrazine-2-carboxamide;5-amino-N-(cyclopentylmethyl)-6-(6-methyl-1H-benzimidazol-2-yl)pyrazine-2-carboxamide;5-amino-6-(6-methyl-1H-benzimidazol-2-yl)-N-(oxolan-2-ylmethyl)pyrazine-2-carboxamide;[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]-morpholin-4-ylmethanone;5-amino-6-(6-methyl-1H-benzimidazol-2-yl)-N-(2-pyrrolidin-1-ylethyl)pyrazine-2-carboxamide;molecular hydrogen (PubChem CID 159647198) has the molecular formula C88H134N32O8 and a molecular weight of 1768.26 g/mol. Its IUPAC name is 5-amino-N-(2-amino-2-oxoethyl)-6-(6-methyl-1H-benzimidazol-2-yl)pyrazine-2-carboxamide;5-amino-N-(cyclopentylmethyl)-6-(6-methyl-1H-benzimidazol-2-yl)pyrazine-2-carboxamide;5-amino-6-(6-methyl-1H-benzimidazol-2-yl)-N-(oxolan-2-ylmethyl)pyrazine-2-carboxamide;[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]-morpholin-4-ylmethanone;5-amino-6-(6-methyl-1H-benzimidazol-2-yl)-N-(2-pyrrolidin-1-ylethyl)pyrazine-2-carboxamide;molecular hydrogen.

Molecular Properties

• Compound Name: 5-amino-N-(2-amino-2-oxoethyl)-6-(6-methyl-1H-benzimidazol-2-yl)pyrazine-2-carboxamide;5-amino-N-(cyclopentylmethyl)-6-(6-methyl-1H-benzimidazol-2-yl)pyrazine-2-carboxamide;5-amino-6-(6-methyl-1H-benzimidazol-2-yl)-N-(oxolan-2-ylmethyl)pyrazine-2-carboxamide;[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]-morpholin-4-ylmethanone;5-amino-6-(6-methyl-1H-benzimidazol-2-yl)-N-(2-pyrrolidin-1-ylethyl)pyrazine-2-carboxamide;molecular hydrogen
• PubChem CID: 159647198
• Molecular Formula: C88H134N32O8
• Molecular Weight: 1768.26 g/mol
• Exact Mass: 1767.11
• IUPAC Name: 5-amino-N-(2-amino-2-oxoethyl)-6-(6-methyl-1H-benzimidazol-2-yl)pyrazine-2-carboxamide;5-amino-N-(cyclopentylmethyl)-6-(6-methyl-1H-benzimidazol-2-yl)pyrazine-2-carboxamide;5-amino-6-(6-methyl-1H-benzimidazol-2-yl)-N-(oxolan-2-ylmethyl)pyrazine-2-carboxamide;[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]-morpholin-4-ylmethanone;5-amino-6-(6-methyl-1H-benzimidazol-2-yl)-N-(2-pyrrolidin-1-ylethyl)pyrazine-2-carboxamide;molecular hydrogen
• SMILES: Cc1ccc2nc(-c3nc(C(=O)N4CCOCC4)cnc3N)[nH]c2c1.Cc1ccc2nc(-c3nc(C(=O)NCC(N)=O)cnc3N)[nH]c2c1.Cc1ccc2nc(-c3nc(C(=O)NCC4CCCC4)cnc3N)[nH]c2c1.Cc1ccc2nc(-c3nc(C(=O)NCC4CCCO4)cnc3N)[nH]c2c1.Cc1ccc2nc(-c3nc(C(=O)NCCN4CCCC4)cnc3N)[nH]c2c1.[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H]
• InChI: InChI=1S/C19H23N7O.C19H22N6O.C18H20N6O2.C17H18N6O2.C15H15N7O2.18H2/c1-12-4-5-13-14(10-12)25-18(24-13)16-17(20)22-11-15(23-16)19(27)21-6-9-26-7-2-3-8-26;1-11-6-7-13-14(8-11)25-18(24-13)16-17(20)21-10-15(23-16)19(26)22-9-12-4-2-3-5-12;1-10-4-5-12-13(7-10)24-17(23-12)15-16(19)20-9-14(22-15)18(25)21-8-11-3-2-6-26-11;1-10-2-3-11-12(8-10)22-16(21-11)14-15(18)19-9-13(20-14)17(24)23-4-6-25-7-5-23;1-7-2-3-8-9(4-7)22-14(21-8)12-13(17)18-5-10(20-12)15(24)19-6-11(16)23;;;;;;;;;;;;;;;;;;/h4-5,10-11H,2-3,6-9H2,1H3,(H2,20,22)(H,21,27)(H,24,25);6-8,10,12H,2-5,9H2,1H3,(H2,20,21)(H,22,26)(H,24,25);4-5,7,9,11H,2-3,6,8H2,1H3,(H2,19,20)(H,21,25)(H,23,24);2-3,8-9H,4-7H2,1H3,(H2,18,19)(H,21,22);2-5H,6H2,1H3,(H2,16,23)(H2,17,18)(H,19,24)(H,21,22);18*1H
• InChIKey: MRCJUPXBFBDBGU-UHFFFAOYSA-N
• XLogP: 12.32
• TPSA: 603.90 Ų
• H-Bond Donors: 15
• H-Bond Acceptors: 29
• Rotatable Bonds: 19
• Heavy Atoms: 128
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	1768.26
LogP ≤ 5	12.32
H-Bond Donors ≤ 5	15
H-Bond Acceptors ≤ 10	29

Frequently Asked Questions

What is the IUPAC name of 5-amino-N-(2-amino-2-oxoethyl)-6-(6-methyl-1H-benzimidazol-2-yl)pyrazine-2-carboxamide;5-amino-N-(cyclopentylmethyl)-6-(6-methyl-1H-benzimidazol-2-yl)pyrazine-2-carboxamide;5-amino-6-(6-methyl-1H-benzimidazol-2-yl)-N-(oxolan-2-ylmethyl)pyrazine-2-carboxamide;[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]-morpholin-4-ylmethanone;5-amino-6-(6-methyl-1H-benzimidazol-2-yl)-N-(2-pyrrolidin-1-ylethyl)pyrazine-2-carboxamide;molecular hydrogen?

The IUPAC name of 5-amino-N-(2-amino-2-oxoethyl)-6-(6-methyl-1H-benzimidazol-2-yl)pyrazine-2-carboxamide;5-amino-N-(cyclopentylmethyl)-6-(6-methyl-1H-benzimidazol-2-yl)pyrazine-2-carboxamide;5-amino-6-(6-methyl-1H-benzimidazol-2-yl)-N-(oxolan-2-ylmethyl)pyrazine-2-carboxamide;[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]-morpholin-4-ylmethanone;5-amino-6-(6-methyl-1H-benzimidazol-2-yl)-N-(2-pyrrolidin-1-ylethyl)pyrazine-2-carboxamide;molecular hydrogen (CID 159647198) is 5-amino-N-(2-amino-2-oxoethyl)-6-(6-methyl-1H-benzimidazol-2-yl)pyrazine-2-carboxamide;5-amino-N-(cyclopentylmethyl)-6-(6-methyl-1H-benzimidazol-2-yl)pyrazine-2-carboxamide;5-amino-6-(6-methyl-1H-benzimidazol-2-yl)-N-(oxolan-2-ylmethyl)pyrazine-2-carboxamide;[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]-morpholin-4-ylmethanone;5-amino-6-(6-methyl-1H-benzimidazol-2-yl)-N-(2-pyrrolidin-1-ylethyl)pyrazine-2-carboxamide;molecular hydrogen.

What is the SMILES notation for 5-amino-N-(2-amino-2-oxoethyl)-6-(6-methyl-1H-benzimidazol-2-yl)pyrazine-2-carboxamide;5-amino-N-(cyclopentylmethyl)-6-(6-methyl-1H-benzimidazol-2-yl)pyrazine-2-carboxamide;5-amino-6-(6-methyl-1H-benzimidazol-2-yl)-N-(oxolan-2-ylmethyl)pyrazine-2-carboxamide;[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]-morpholin-4-ylmethanone;5-amino-6-(6-methyl-1H-benzimidazol-2-yl)-N-(2-pyrrolidin-1-ylethyl)pyrazine-2-carboxamide;molecular hydrogen?

The canonical SMILES for 5-amino-N-(2-amino-2-oxoethyl)-6-(6-methyl-1H-benzimidazol-2-yl)pyrazine-2-carboxamide;5-amino-N-(cyclopentylmethyl)-6-(6-methyl-1H-benzimidazol-2-yl)pyrazine-2-carboxamide;5-amino-6-(6-methyl-1H-benzimidazol-2-yl)-N-(oxolan-2-ylmethyl)pyrazine-2-carboxamide;[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]-morpholin-4-ylmethanone;5-amino-6-(6-methyl-1H-benzimidazol-2-yl)-N-(2-pyrrolidin-1-ylethyl)pyrazine-2-carboxamide;molecular hydrogen is Cc1ccc2nc(-c3nc(C(=O)N4CCOCC4)cnc3N)[nH]c2c1.Cc1ccc2nc(-c3nc(C(=O)NCC(N)=O)cnc3N)[nH]c2c1.Cc1ccc2nc(-c3nc(C(=O)NCC4CCCC4)cnc3N)[nH]c2c1.Cc1ccc2nc(-c3nc(C(=O)NCC4CCCO4)cnc3N)[nH]c2c1.Cc1ccc2nc(-c3nc(C(=O)NCCN4CCCC4)cnc3N)[nH]c2c1.[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].

What is the InChIKey of 5-amino-N-(2-amino-2-oxoethyl)-6-(6-methyl-1H-benzimidazol-2-yl)pyrazine-2-carboxamide;5-amino-N-(cyclopentylmethyl)-6-(6-methyl-1H-benzimidazol-2-yl)pyrazine-2-carboxamide;5-amino-6-(6-methyl-1H-benzimidazol-2-yl)-N-(oxolan-2-ylmethyl)pyrazine-2-carboxamide;[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]-morpholin-4-ylmethanone;5-amino-6-(6-methyl-1H-benzimidazol-2-yl)-N-(2-pyrrolidin-1-ylethyl)pyrazine-2-carboxamide;molecular hydrogen?

The InChIKey is MRCJUPXBFBDBGU-UHFFFAOYSA-N. The full InChI is InChI=1S/C19H23N7O.C19H22N6O.C18H20N6O2.C17H18N6O2.C15H15N7O2.18H2/c1-12-4-5-13-14(10-12)25-18(24-13)16-17(20)22-11-15(23-16)19(27)21-6-9-26-7-2-3-8-26;1-11-6-7-13-14(8-11)25-18(24-13)16-17(20)21-10-15(23-16)19(26)22-9-12-4-2-3-5-12;1-10-4-5-12-13(7-10)24-17(23-12)15-16(19)20-9-14(22-15)18(25)21-8-11-3-2-6-26-11;1-10-2-3-11-12(8-10)22-16(21-11)14-15(18)19-9-13(20-14)17(24)23-4-6-25-7-5-23;1-7-2-3-8-9(4-7)22-14(21-8)12-13(17)18-5-10(20-12)15(24)19-6-11(16)23;;;;;;;;;;;;;;;;;;/h4-5,10-11H,2-3,6-9H2,1H3,(H2,20,22)(H,21,27)(H,24,25);6-8,10,12H,2-5,9H2,1H3,(H2,20,21)(H,22,26)(H,24,25);4-5,7,9,11H,2-3,6,8H2,1H3,(H2,19,20)(H,21,25)(H,23,24);2-3,8-9H,4-7H2,1H3,(H2,18,19)(H,21,22);2-5H,6H2,1H3,(H2,16,23)(H2,17,18)(H,19,24)(H,21,22);18*1H.

What are the key properties of 5-amino-N-(2-amino-2-oxoethyl)-6-(6-methyl-1H-benzimidazol-2-yl)pyrazine-2-carboxamide;5-amino-N-(cyclopentylmethyl)-6-(6-methyl-1H-benzimidazol-2-yl)pyrazine-2-carboxamide;5-amino-6-(6-methyl-1H-benzimidazol-2-yl)-N-(oxolan-2-ylmethyl)pyrazine-2-carboxamide;[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]-morpholin-4-ylmethanone;5-amino-6-(6-methyl-1H-benzimidazol-2-yl)-N-(2-pyrrolidin-1-ylethyl)pyrazine-2-carboxamide;molecular hydrogen?

5-amino-N-(2-amino-2-oxoethyl)-6-(6-methyl-1H-benzimidazol-2-yl)pyrazine-2-carboxamide;5-amino-N-(cyclopentylmethyl)-6-(6-methyl-1H-benzimidazol-2-yl)pyrazine-2-carboxamide;5-amino-6-(6-methyl-1H-benzimidazol-2-yl)-N-(oxolan-2-ylmethyl)pyrazine-2-carboxamide;[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]-morpholin-4-ylmethanone;5-amino-6-(6-methyl-1H-benzimidazol-2-yl)-N-(2-pyrrolidin-1-ylethyl)pyrazine-2-carboxamide;molecular hydrogen has a molecular weight of 1768.26 g/mol, XLogP of 12.32, 19 rotatable bonds, 15 hydrogen bond donors, and 29 hydrogen bond acceptors.

Where does this data come from?

All data for 5-amino-N-(2-amino-2-oxoethyl)-6-(6-methyl-1H-benzimidazol-2-yl)pyrazine-2-carboxamide;5-amino-N-(cyclopentylmethyl)-6-(6-methyl-1H-benzimidazol-2-yl)pyrazine-2-carboxamide;5-amino-6-(6-methyl-1H-benzimidazol-2-yl)-N-(oxolan-2-ylmethyl)pyrazine-2-carboxamide;[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]-morpholin-4-ylmethanone;5-amino-6-(6-methyl-1H-benzimidazol-2-yl)-N-(2-pyrrolidin-1-ylethyl)pyrazine-2-carboxamide;molecular hydrogen is sourced from PubChem (CID 159647198), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).